'Remdesivir helps decrease hospital stay, but has no benefit on mortality': AIIMS Director

Amidst Coronavirus pandemic, Remdesivir has emerged as one of most promising drugs for treatment of COVID-19. However, it has been found that anti-viral drug helps in decreasing duration of COVID-19 patients' stay in hospital but does t appear to show any benefits when it comes to mortality. According to reports, in dition to hydroxychloroquine (HCQ), Remdesivir is also a commonly used drug that is being used to treat COVID-19 patients.

Remdesivir currently in short supply

According to reports, All India Institute of Medical Sciences (AIIMS), New Delhi Director Dr Randeep Guleria said, "re is definite anti-viral drug which has been proved as far as COVID-19 is concerned. A lot of research is going on. re are some anti-viral drugs which are being used, one of m is 'Remdesivir' that is being me by a company from US. Data suggests that it helps to decrease hospital stay but it doesn't show benefit as far as death or mortality benefit is concerned. So we need more data to suggest that se drugs are useful or t."

Dr Guleria ded that currently Remdesivir is being used and given to patients in accordance with prescribed guidelines of emergency use authorisation. re is currently very limited stock of drug and Dr Guleria hopes to procure more of it in coming weeks.

Re: Number Of Coronavirus Cases Tops 3,000 In rth Dakota

Re: Tennessee Senate OKs Bill To Limit Coronavirus Liability

Dr Guleria furr ded, "Repurposed drugs are available in market and studies, too, have suggested that y may have anti-viral activities and refore y can be used. drug which we use commonly for treating coronavirus patients is hydroxychloroquine (HCQ). re are controversies regarding drug but data suggests that it may be useful especially in early days."

Re: Researchers Ask If Survivor Plasma Could Prevent Coronavirus

Re: Ukraine: President Volodymyr Zelenskiy's Wife Tests Positive For Coronavirus

Dr Guleria also spoke about convalescent plasma rapy wherein infected patients are given plasma containing anti-bodies obtained from people who have recovered from COVID-19, hoping that anti-bodies will help fight coronavirus. "se are still evolving treatments and some may be useful and some may t be that useful. But treatment currently remains supportive care oxygenation. As many as 90 to 95 percent of patients with good supportive care oxygenation actually recovery and become alright," he ded.

(Input Credit ANI) (Picture credit: AP)